Prosthetic Treatment Guidelines for Patients Undergoing GLP-1 Medication Weight-Loss Therapy: A Multidisciplinary Team Approach to Managing the Rise of Ozempic Use in Individuals with Limb Loss
Clinical Director Coyote Middletown, New York, United States
As the use of GLP-1 medications rises among prosthetic users, prosthetists face new challenges in managing limb volume fluctuations and overall prosthetic care. This research explores the impact of GLP-1 medications on amputees, while drawing on insights from a multidisciplinary team of prosthetists, physicians, surgeons, and physical therapists.
Learning Objectives:
Upon completion, participants will be able to list various side effects and expected results from patients using GLP-1 medications and prostheses.
At the end of the presentation, participants will be able to conduct improved patient fittings and treatment plans for individuals with rapid weight loss.
Upon completion, participants will be able to discuss specific areas in their documentation which need to be improved upon for assisting with insurance coverage.
.png)
